484 related articles for article (PubMed ID: 15663995)
1. The role of Vitamin D3 metabolism in prostate cancer.
Lou YR; Qiao S; Talonpoika R; Syvälä H; Tuohimaa P
J Steroid Biochem Mol Biol; 2004 Nov; 92(4):317-25. PubMed ID: 15663995
[TBL] [Abstract][Full Text] [Related]
2. Altered pharmacokinetics of 1alpha,25-dihydroxyvitamin D3 and 25-hydroxyvitamin D3 in the blood and tissues of the 25-hydroxyvitamin D-24-hydroxylase (Cyp24a1) null mouse.
Masuda S; Byford V; Arabian A; Sakai Y; Demay MB; St-Arnaud R; Jones G
Endocrinology; 2005 Feb; 146(2):825-34. PubMed ID: 15498883
[TBL] [Abstract][Full Text] [Related]
3. Anti-proliferative activity of 25-hydroxyvitamin D3 in human prostate cells.
Munetsuna E; Kawanami R; Nishikawa M; Ikeda S; Nakabayashi S; Yasuda K; Ohta M; Kamakura M; Ikushiro S; Sakaki T
Mol Cell Endocrinol; 2014 Feb; 382(2):960-70. PubMed ID: 24291609
[TBL] [Abstract][Full Text] [Related]
4. Kinetic studies of 25-hydroxy-19-nor-vitamin D3 and 1 alpha,25-dihydroxy-19-nor-vitamin D3 hydroxylation by CYP27B1 and CYP24A1.
Urushino N; Nakabayashi S; Arai MA; Kittaka A; Chen TC; Yamamoto K; Hayashi K; Kato S; Ohta M; Kamakura M; Ikushiro S; Sakaki T
Drug Metab Dispos; 2007 Sep; 35(9):1482-8. PubMed ID: 17553915
[TBL] [Abstract][Full Text] [Related]
5. Clonal differences in expression of 25-hydroxyvitamin D(3)-1alpha-hydroxylase, of 25-hydroxyvitamin D(3)-24-hydroxylase, and of the vitamin D receptor in human colon carcinoma cells: effects of epidermal growth factor and 1alpha,25-dihydroxyvitamin D(3).
Bareis P; Kállay E; Bischof MG; Bises G; Hofer H; Pötzi C; Manhardt T; Bland R; Cross HS
Exp Cell Res; 2002 Jun; 276(2):320-7. PubMed ID: 12027461
[TBL] [Abstract][Full Text] [Related]
6. Actions of vitamin D3, analogs on human prostate cancer cell lines: comparison with 1,25-dihydroxyvitamin D3.
Skowronski RJ; Peehl DM; Feldman D
Endocrinology; 1995 Jan; 136(1):20-6. PubMed ID: 7530193
[TBL] [Abstract][Full Text] [Related]
7. Vitamin D metabolism in human prostate cells: implications for prostate cancer chemoprevention by vitamin D.
Flanagan JN; Young MV; Persons KS; Wang L; Mathieu JS; Whitlatch LW; Holick MF; Chen TC
Anticancer Res; 2006; 26(4A):2567-72. PubMed ID: 16886665
[TBL] [Abstract][Full Text] [Related]
8. 25-hydroxyvitamin D3 is an active hormone in human primary prostatic stromal cells.
Lou YR; Laaksi I; Syvälä H; Bläuer M; Tammela TL; Ylikomi T; Tuohimaa P
FASEB J; 2004 Feb; 18(2):332-4. PubMed ID: 14657005
[TBL] [Abstract][Full Text] [Related]
9. Autocrine metabolism of vitamin D in normal and malignant breast tissue.
Townsend K; Banwell CM; Guy M; Colston KW; Mansi JL; Stewart PM; Campbell MJ; Hewison M
Clin Cancer Res; 2005 May; 11(9):3579-86. PubMed ID: 15867263
[TBL] [Abstract][Full Text] [Related]
10. 25(OH)D3 and 1,25(OH)2D3 serum concentration and breast tissue expression of 1alpha-hydroxylase, 24-hydroxylase and Vitamin D receptor in women with and without breast cancer.
de Lyra EC; da Silva IA; Katayama ML; Brentani MM; Nonogaki S; Góes JC; Folgueira MA
J Steroid Biochem Mol Biol; 2006 Aug; 100(4-5):184-92. PubMed ID: 16828283
[TBL] [Abstract][Full Text] [Related]
11. Vitamin D(3) metabolism in human glioblastoma multiforme: functionality of CYP27B1 splice variants, metabolism of calcidiol, and effect of calcitriol.
Diesel B; Radermacher J; Bureik M; Bernhardt R; Seifert M; Reichrath J; Fischer U; Meese E
Clin Cancer Res; 2005 Aug; 11(15):5370-80. PubMed ID: 16061850
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic regulation of vitamin D hydroxylase expression and activity in normal and malignant human prostate cells.
Khorchide M; Lechner D; Cross HS
J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):167-72. PubMed ID: 15860259
[TBL] [Abstract][Full Text] [Related]
13. Vitamin D receptor expression, 24-hydroxylase activity, and inhibition of growth by 1alpha,25-dihydroxyvitamin D3 in seven human prostatic carcinoma cell lines.
Miller GJ; Stapleton GE; Hedlund TE; Moffat KA
Clin Cancer Res; 1995 Sep; 1(9):997-1003. PubMed ID: 9816072
[TBL] [Abstract][Full Text] [Related]
14. Role of 24-hydroxylase in vitamin D3 growth response of OVCAR-3 ovarian cancer cells.
Miettinen S; Ahonen MH; Lou YR; Manninen T; Tuohimaa P; Syvälä H; Ylikomi T
Int J Cancer; 2004 Jan; 108(3):367-73. PubMed ID: 14648702
[TBL] [Abstract][Full Text] [Related]
15. 25-Hydroxyvitamin D(3) is an agonistic vitamin D receptor ligand.
Lou YR; Molnár F; Peräkylä M; Qiao S; Kalueff AV; St-Arnaud R; Carlberg C; Tuohimaa P
J Steroid Biochem Mol Biol; 2010 Feb; 118(3):162-70. PubMed ID: 19944755
[TBL] [Abstract][Full Text] [Related]
16. Mechanism of the anti-proliferative action of 25-hydroxy-19-nor-vitamin D(3) in human prostate cells.
Munetsuna E; Nakabayashi S; Kawanami R; Yasuda K; Ohta M; Arai MA; Kittaka A; Chen TC; Kamakura M; Ikushiro S; Sakaki T
J Mol Endocrinol; 2011 Oct; 47(2):209-18. PubMed ID: 21693624
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of proliferation and induction of apoptosis by 25-hydroxyvitamin D3-3beta-(2)-Bromoacetate, a nontoxic and vitamin D receptor-alkylating analog of 25-hydroxyvitamin D3 in prostate cancer cells.
Swamy N; Chen TC; Peleg S; Dhawan P; Christakos S; Stewart LV; Weigel NL; Mehta RG; Holick MF; Ray R
Clin Cancer Res; 2004 Dec; 10(23):8018-27. PubMed ID: 15585637
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of prostate cancer growth by vitamin D: Regulation of target gene expression.
Krishnan AV; Peehl DM; Feldman D
J Cell Biochem; 2003 Feb; 88(2):363-71. PubMed ID: 12520538
[TBL] [Abstract][Full Text] [Related]
19. Regulation of 25-hydroxyvitamin D3 1alpha-hydroxylase, 1,25-dihydroxyvitamin D3 24-hydroxylase and vitamin D receptor gene expression by 8-bromo cyclic AMP in cultured human syncytiotrophoblast cells.
Avila E; Díaz L; Halhali A; Larrea F
J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):115-9. PubMed ID: 15225757
[TBL] [Abstract][Full Text] [Related]
20. Vitamin D metabolism and action in the prostate: implications for health and disease.
Swami S; Krishnan AV; Feldman D
Mol Cell Endocrinol; 2011 Dec; 347(1-2):61-9. PubMed ID: 21664249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
